CVS CVS Health Corporation | US1266501006
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 426.716.835.060 | 409.423.848.620 | 4.22% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 8,42 | 7,45 | 12.98% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 27 | 26 | 3.85% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |